Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination.
Mesothelial cell monolayers have been reported to prevent infiltration of cancer cells into the peritoneum. We have previously reported that peritoneal fibrosis induced by gastric cancer cells prior to metastatization may provide a congenial environment for peritoneal metastases. In this study, we investigated the effects of peritoneal fibroblasts on peritoneal mesothelial cell morphology. Human gastric cancer (OCUM-2MD3), peritoneal fibroblast (NF-2P) and mesothelial (MS-1) cell lines were established in our laboratory. Histology of the peritoneum was investigated following intraperitoneal inoculation of serum-free conditioned media (SF-CM) from OCUM-2MD3 cells into nude mice. SF-CM from peritoneal fibroblasts was added to monolayer-cultured mesothelial cells, and their morphology was examined by phase-contrast microscopy. This experiment was conducted in the presence and absence of neutralizing antibodies against various factors. Mesothelial cells exposed to fibroblasts proliferation became hemispherical and separated from each other, while unexposed mesothelium remained as a flat monolayer. Cultured-mesothelial cells rounded up or exhibited a fibroblast-like shape following the addition of peritoneal fibroblast SF-CM. Anti-hepatocyte growth factor (HGF) neutralizing antibody partly inhibited this effect. We suggest that soluble factors, such as HGF, produced by peritoneal fibroblasts affect the morphology of mesothelial cells in monolayers so that the resulting environment may become prone to the peritoneal dissemination of cancer cells.
Yashiro
M
M
First Department of Surgery, Osaka City University Medical School, Japan.
Chung
Y S
YS
Inoue
T
T
Nishimura
S
S
Matsuoka
T
T
Fujihara
T
T
Sowa
M
M
D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D002455:Cell Division; D002460:Cell Line; D016895:Culture Media, Serum-Free; D004847:Epithelial Cells; D005347:Fibroblasts / Q000378:metabolism*; D006133:Growth Substances / Q000494:pharmacology; D017228:Hepatocyte Growth Factor / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000494:pharmacology*; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D010537:Peritoneum / Q000166:cytology*; D013274:Stomach Neoplasms / Q000473:pathology; D014407:Tumor Cells, Cultured
D000906:Antibodies; D016895:Culture Media, Serum-Free; D006133:Growth Substances; D017228:Hepatocyte Growth Factor